| Abstract: | Background Use of total laboratory automation (TLA) system has expanded to microbiology and hemostasis and upgraded to second and third generations. We herein report the first successful upgrades and fusion of different versions of the TLA system, thus improving laboratory turnaround time (TAT). Methods A 21‐day schedule was planned from the time of pre‐meeting to installation and clinical sample application. We analyzed the monthly TAT in each menu, distribution of the “out of range for acceptable TAT” samples, and “prolonged time out of acceptable TAT,” before and after the upgrade and fusion. Results We installed and customized hardware, middleware, and software. The one‐way CliniLog 2.0 version track, 50.0‐m long, was changed to a 23.2‐m long one‐way 2.0 version and an 18.7‐m long two‐way 4.0 version. The monthly TAT in the outpatient samples, before and after upgrading the TLA system, were uniformly satisfactory in the chemistry and viral marker menus. However, in the tumor marker menu, the target TAT (98.0% of samples ≤60 minutes) was not satisfied during the familiarization period. There was no significant difference in the proportion of “out of acceptable TAT” samples, before and after the TLA system upgrades (7.4 ‰ and 8.5 ‰) . However, the mean “prolonged time out of acceptable TAT” in the chemistry samples was significantly shortened to 17.4 (±24.0) minutes after the fusion, from 34.5 (±43.4) minutes. Conclusions Despite experimental challenges, a fusion of the TLA system shortened the “prolonged time out of acceptable TAT,” indicating a distribution change in overall TAT. |
